Post by
Biotech010 on Jan 19, 2021 11:59am
GRTS +85% on COVID vaccine... its time IMV!
Gritstone is developing a second generation vaccine against SARS-CoV-2, the virus that causes COVID-19, with potential for both prolonged protection and potency, including against emerging Spike mutant forms of SARS-CoV-2.
The stock is going crazy +95% as I type this. We all know IMV is also working on the new mutants so we can expect a big jump if they finally start the phase 1-2 trial!
Comment by
qwerty22 on Jan 19, 2021 10:30pm
My view the company has always been making the right noises at the right time when it comes to Covid. The thing they don't have is the collaboration with NIAID. I guess people think Gritstone will be the next Moderna.